A BPC-157 Certificate of Analysis (COA) generated via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) provides quantitative documentation of peptide purity, molecular identity, and residual contaminant profiles. For laboratory investigators, reviewing lot-specific HPLC chromatograms and mass spectrometry spectra ensures chemical fidelity and reproducibility across preclinical cellular and animal research models.
A BPC-157 Certificate of Analysis (COA) generated via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) provides quantitative documentation of peptide purity, molecular identity, and residual contaminant profiles. For laboratory investigators, reviewing lot-specific HPLC chromatograms and mass spectrometry spectra ensures chemical fidelity and reproducibility across preclinical cellular and animal research models.
In peptide chemistry and preclinical evaluation, obtaining an authentic Certificate of Analysis (COA) supported by Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) is mandatory for validating experimental integrity. BPC-157 is a pentadecapeptide derived from human gastric juice protein sequences, synthesized via solid-phase peptide synthesis (SPPS). Because chemical synthesis can generate truncated sequences, deletion peptides, and side-chain protecting group adducts, raw HPLC data must accompany every research lot to confirm target purity.
A compliant BPC-157 COA presents the exact retention time, peak area percentages, total purity rating (typically targeting >99.0%), and mass verification matching the theoretical molecular weight of 1419.53 g/mol. PX1 Research mandates third-party testing conducted in ISO 17025 accredited facilities, ensuring that laboratory researchers receive uncompromised research peptides supported by fully transparent analytical documentation.
BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. As a synthetic fragment of a naturally occurring gastric peptide, BPC-157 exhibits notable stability in aqueous solutions across a broad pH range, making it a focus of extensive preclinical investigation.
In rodent and in vitro models, BPC-157 is primarily studied as a tissue repair peptide. Experimental literature indicates that it promotes the accelerated repair of tendon, ligament, skeletal muscle, and gut lining tissue. The underlying mechanism involves the upregulation of vascular endothelial growth factor (VEGF) expression, early activation of the FAK-paxillin pathway, and enhanced cellular migration to injury sites. Researchers evaluating angiogenesis and extracellular matrix remodeling frequently utilize high-purity BPC-157 to study these focal adhesion dynamics.
Reversed-Phase High-Performance Liquid Chromatography isolates BPC-157 from synthetic side products based on hydrophobic interactions with a stationary phase (typically C18 silica columns). As a mobile phase gradient of water and acetonitrile (containing 0.1% trifluoroacetic acid) passes through the column, the target peptide elutes at a characteristic retention time measured by a UV detector at 214 nm or 220 nm.
When evaluating a peptide purity report, investigators should observe a single, sharp principal peak representing BPC-157. Minor secondary peaks reflect closely related synthetic impurities. High-purity reference standards demand that the integrated area under the primary peak constitutes no less than 98% to 99% of the total integrated area. Any broad or split peaks indicate degraded material, improper column loading, or co-eluting contaminants that compromise experimental reproducibility.
While RP-HPLC establishes chemical purity by measuring peak areas, it cannot definitively confirm that the primary peak corresponds to BPC-157. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is required to determine precise molecular mass.
The monoisotopic mass of BPC-157 is approximately 1418.70 Da, with a average molecular weight of 1419.53 g/mol. Mass spectra in a comprehensive COA display clear protonated ion peaks, such as [M+H]+ at m/z 1420.5 and doubly charged species [M+2H]2+ at m/z 710.8. Verification of these exact mass-to-charge ratios confirms that the synthesized peptide matches the intended sequence without structural mutations or unremoved protecting groups.
For cell culture assays and animal models, sequence purity alone is insufficient. Bacterial endotoxins—lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes—can trigger unspecific inflammatory cascades, skewing gene expression data and cellular viability assays.
PX1 Research subjects every lot of BPC-157 to Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing to quantify endotoxin units (EU/mg). Maintaining endotoxin levels below strictly defined thresholds (<0.05 EU/mg) ensures that cellular migration, macrophage activation, and angiogenic responses observed in vitro are driven exclusively by BPC-157 activity rather than immunogenic artifacts.
Laboratory researchers reviewing documentation from PX1 Research will find standardized reporting parameters designed to streamline quality compliance for institutional procurement. Each lot-specific COA includes:
1. Product Name & Chemical Sequence: Verification of BPC-157 and 15-amino acid sequence. 2. Lot/Batch Identification Number: Full physical traceability from synthesis to final lyophilization. 3. Physical Appearance: White to off-white lyophilized powder confirmation. 4. Identity (ESI-MS): Experimental m/z matching theoretical molecular mass within ±1 Da. 5. Purity (RP-HPLC): Integrated peak area percentage (>99.0% threshold). 6. Endotoxin Quantification: Measured in EU/mg via LAL/rFC method. 7. Solvent Residue Analysis: Quantated gas chromatography testing for residual organic solvents.
Researchers can access our complete repository of batch documentation via our dedicated research library hub or contact our technical team for institutional compliance audits.
Preclinical tissue regeneration protocols often investigate BPC-157 alongside complementary peptides that target distinct signaling mechanisms. Understanding the operational differences between these compounds helps researchers select appropriate agents for comparative or combination assays.
While BPC-157 acts primarily on focal adhesion kinase (FAK) signaling, nitric oxide pathway modulation, and localized VEGFR2 upregulation, TB-500 (Thymosin Beta-4 active fragment) operates via actin monomer sequestration, promoting systemic cell migration and cytoskeletal reorganization. Concurrently, GHK-Cu functions as a copper-binding tripeptide that modulates collagen synthesis, matrix metalloproteinase (MMP) transcription, and anti-inflammatory remodeling pathways. Evaluating these compounds side-by-side in rodent models provides multi-faceted insights into wound healing kinetics.
Lyophilized BPC-157 is stable at room temperature for brief transit periods but should be stored at -20°C upon receipt for long-term preservation. Exposure to moisture, heat, and ultraviolet light accelerates peptide bond hydrolysis and methionine oxidation.
When preparing solutions for in vitro or ex vivo assays, researchers should reconstitute the lyophilized cake using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Gentle swirl agitation is recommended; high-shear vortexing can induce mechanical shear stress and peptide aggregation. Reconstituted aliquots must be stored at 2°C to 8°C and evaluated within short experimental windows, or flash-frozen at -80°C to prevent degradation across repeated freeze-thaw cycles.
Sourcing research peptides requires strict adherence to quality management systems. PX1 Research synthesizes and processes compounds in USA-based, GMP-compliant facilities. By integrating ISO 17025 accredited third-party testing for every single lot, PX1 eliminates batch-to-batch variation and unverified purity metrics.
Academic laboratories, biotechnology firms, and contract research organizations requiring large-scale allocations can access bulk supply options through our wholesale lab-account portal. Every shipment originates from our CA and AZ distribution hubs, ensuring rapid dispatch with verified temperature control parameters.
What does an HPLC purity percentage on a BPC-157 COA mean?
The HPLC purity percentage represents the integrated peak area of target BPC-157 relative to all detected peptide-related impurities at a specific UV wavelength (typically 214 nm). A 99% rating means 99% of the UV-absorbing peptide material in the sample corresponds to BPC-157.
Why is mass spectrometry (MS) necessary alongside HPLC?
HPLC measures relative chemical purity based on retention time, but cannot independently confirm molecular structure. Mass spectrometry measures the exact mass-to-charge ratio (m/z), verifying that the peptide sequence matches the theoretical molecular mass of BPC-157 (1419.53 g/mol).
What endotoxin limit is acceptable for BPC-157 in cell culture studies?
For robust in vitro assays and animal studies, endotoxin levels should ideally remain below 0.05 EU/mg. Higher endotoxin levels can trigger non-specific toll-like receptor (TLR) activation, introducing inflammatory noise into experimental data.
How should BPC-157 be stored upon delivery to the lab?
Lyophilized BPC-157 powder should be stored at -20°C or -80°C in a desiccated environment to maintain long-term stability. Once reconstituted in sterile aqueous buffer, aliquots should be kept at 2°C to 8°C for short-term use or stored at -80°C.
What standard reconstitution solvents are recommended for laboratory research?
Sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) are standard diluents for laboratory reconstitution depending on the target assay design.
How does PX1 Research verify lot-to-lot consistency for BPC-157?
Every production batch undergoes independent, third-party testing in ISO 17025 accredited laboratories using RP-HPLC and ESI-MS, supplemented by bioburden and endotoxin assays. Analytical certificates are linked directly to unique lot numbers.
How does BPC-157 differ mechanistically from TB-500 in preclinical models?
BPC-157 primarily targets focal adhesion kinase (FAK) activation, nitric oxide synthesis, and localized VEGFR2 expression, whereas TB-500 operates via actin monomer sequestration (G-actin binding) to influence systemic cell motility and cytoskeletal structure.
Are PX1 Research peptides authorized for human consumption or therapeutic use?
No. All PX1 Research products, including BPC-157, are strictly manufactured and sold for in vitro, laboratory, and preclinical research use only. They are not for human or animal consumption, diagnostic, or therapeutic application.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.